Strategies for Enriching Variant Coverage in Candidate Disease Loci on a Multiethnic Genotyping Array
- PMID: 27973554
- PMCID: PMC5156387
- DOI: 10.1371/journal.pone.0167758
Strategies for Enriching Variant Coverage in Candidate Disease Loci on a Multiethnic Genotyping Array
Abstract
Investigating genetic architecture of complex traits in ancestrally diverse populations is imperative to understand the etiology of disease. However, the current paucity of genetic research in people of African and Latin American ancestry, Hispanic and indigenous peoples in the United States is likely to exacerbate existing health disparities for many common diseases. The Population Architecture using Genomics and Epidemiology, Phase II (PAGE II), Study was initiated in 2013 by the National Human Genome Research Institute to expand our understanding of complex trait loci in ethnically diverse and well characterized study populations. To meet this goal, the Multi-Ethnic Genotyping Array (MEGA) was designed to substantially improve fine-mapping and functional discovery by increasing variant coverage across multiple ethnicities at known loci for metabolic, cardiovascular, renal, inflammatory, anthropometric, and a variety of lifestyle traits. Studying the frequency distribution of clinically relevant mutations, putative risk alleles, and known functional variants across multiple populations will provide important insight into the genetic architecture of complex diseases and facilitate the discovery of novel, sometimes population-specific, disease associations. DNA samples from 51,650 self-identified African ancestry (17,328), Hispanic/Latino (22,379), Asian/Pacific Islander (8,640), and American Indian (653) and an additional 2,650 participants of either South Asian or European ancestry, and other reference panels have been genotyped on MEGA by PAGE II. MEGA was designed as a new resource for studying ancestrally diverse populations. Here, we describe the methodology for selecting trait-specific content for use in multi-ethnic populations and how enriching MEGA for this content may contribute to deeper biological understanding of the genetic etiology of complex disease.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Matise TC, Ambite JL, Buyske S, Carlson CS, Cole SA, Crawford DC et al. (2011) The Next PAGE in understanding complex traits: design for the analysis of Population Architecture Using Genetics and Epidemiology (PAGE) Study. Am J Epidemiol 174: 849–859. kwr160 [pii]. 10.1093/aje/kwr160 - DOI - PMC - PubMed
-
- The Women's Health Initiative Study Group. (1998) Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 19: 61–109. S0197245697000780 [pii]. - PubMed
MeSH terms
Grants and funding
- U01 HL041642/HL/NHLBI NIH HHS/United States
- U01 HL041654/HL/NHLBI NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- N01 WH022110/WH/WHI NIH HHS/United States
- N01 HC048049/HL/NHLBI NIH HHS/United States
- U01 HL041652/HL/NHLBI NIH HHS/United States
- N01 HC045205/HL/NHLBI NIH HHS/United States
- N01 HC055020/HL/NHLBI NIH HHS/United States
- N01 HC048047/HL/NHLBI NIH HHS/United States
- N01 HC075150/HL/NHLBI NIH HHS/United States
- U01 HL065520/HL/NHLBI NIH HHS/United States
- U01 HG004801/HG/NHGRI NIH HHS/United States
- N01 HC095095/HL/NHLBI NIH HHS/United States
- N01 HC055016/HL/NHLBI NIH HHS/United States
- N01 HC048048/HL/NHLBI NIH HHS/United States
- N01 HC055019/HL/NHLBI NIH HHS/United States
- U01 HG004790/HG/NHGRI NIH HHS/United States
- N01 HC065233/HL/NHLBI NIH HHS/United States
- U01 HG004802/HG/NHGRI NIH HHS/United States
- N01 HC065236/HL/NHLBI NIH HHS/United States
- N01 HC055021/HL/NHLBI NIH HHS/United States
- N01 HC065235/HL/NHLBI NIH HHS/United States
- N01 HC015103/HC/NHLBI NIH HHS/United States
- N01 HC085086/HL/NHLBI NIH HHS/United States
- N01 HC055015/HL/NHLBI NIH HHS/United States
- U01 HG007376/HG/NHGRI NIH HHS/United States
- R01 HL087652/HL/NHLBI NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- N01 HC065234/HL/NHLBI NIH HHS/United States
- N01 HC055222/HL/NHLBI NIH HHS/United States
- U01 HG004803/HG/NHGRI NIH HHS/United States
- P01 CA033619/CA/NCI NIH HHS/United States
- T32 HD049311/HD/NICHD NIH HHS/United States
- N01 HC045134/HC/NHLBI NIH HHS/United States
- N01 HC005187/HL/NHLBI NIH HHS/United States
- N01 HC085079/HL/NHLBI NIH HHS/United States
- N01 HC055018/HL/NHLBI NIH HHS/United States
- M01 RR000425/RR/NCRR NIH HHS/United States
- N01 HC048050/HL/NHLBI NIH HHS/United States
- U01 CA098758/CA/NCI NIH HHS/United States
- U01 HL065521/HL/NHLBI NIH HHS/United States
- S10 OD020069/OD/NIH HHS/United States
- N01 HC055022/HL/NHLBI NIH HHS/United States
- T32 GM007790/GM/NIGMS NIH HHS/United States
- P2C HD050924/HD/NICHD NIH HHS/United States
- N01 HC045133/HC/NHLBI NIH HHS/United States
- U01 CA136792/CA/NCI NIH HHS/United States
- N01 HC065237/HL/NHLBI NIH HHS/United States
- P30 CA071789/CA/NCI NIH HHS/United States
- U01 HG007397/HG/NHGRI NIH HHS/United States
- R37 CA054281/CA/NCI NIH HHS/United States
- N01 HC035129/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
